Noopept (omberacetam, GVS-111) is a small synthetic molecule built from two amino acids, developed at the Zakusov Institute of Pharmacology in Moscow as a dipeptide version of the nootropic piracetam. It is not approved for human use in the US.
Also known as: omberacetam, GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester.
There is no FDA-approved noopept product, so there are no US label strengths to list.
Noopept is not approved for human use in the US. A 2021 study (Cohen) bought cognitive supplements labeled as containing omberacetam and other unapproved drugs and tested them: several drugs found were not on the label, several listed drugs were missing, most stated amounts were wrong, and some products would give up to four times a typical drug dose per serving.
Its developers describe it as orally active (Gudasheva 2018). A Russian study found that people clear it more slowly than rats or rabbits, with wide differences between people (Boiko 2004), but the summary gives no numbers. If you take prescription medicines, ask your prescriber or pharmacist before adding it.
The human pharmacokinetic study we found (Boiko 2004, in Russian) reports slower elimination in people than in animals and wide variation between people, but its summary gives no half-life or time to peak. So we do not list the app's modeling values (1 hour and 15 minutes).
How Dose Track handles peptides · Reconstitution calculator · Half-life calculator